The use of quantitative analysis and Hansen solubility parameter predictions for the selection of excipients for lipid nanocarriers to be loaded with water soluble and insoluble compounds

Pedzisai A Makoni; Janeeta Ranchhod; Kasongo WaKasongo; Sandile M Khamanga; Roderick B Walker

doi:10.1016/j.jsps.2020.01.010

The use of quantitative analysis and Hansen solubility parameter predictions for the selection of excipients for lipid nanocarriers to be loaded with water soluble and insoluble compounds

Saudi Pharm J. 2020 Mar;28(3):308-315. doi: 10.1016/j.jsps.2020.01.010. Epub 2020 Jan 31.

Authors

Pedzisai A Makoni¹, Janeeta Ranchhod¹, Kasongo WaKasongo¹, Sandile M Khamanga¹, Roderick B Walker¹

Affiliation

¹ Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa.

Abstract

The aim of these studies was to determine the miscibility of different API with lipid excipients to predict drug loading and encapsulation properties for the production of solid lipid nanoparticles and nanostructured lipid carriers. Five API exhibiting different physicochemical characteristics, viz., clarithromycin, efavirenz, minocycline hydrochloride, mometasone furoate, and didanosine were used and six solid lipids in addition to four liquid lipids were investigated. Determination of solid and liquid lipids with the best solubilization potential for each API were performed using a traditional shake-flask method and/or a modification thereof. Hansen solubility parameters of the API and different solid and liquid lipids were estimated from their chemical structure using Hiroshi Yamamoto's molecular breaking method of Hansen Solubility Parameters in Practice software. Experimental results were in close agreement with solubility parameter predictions for systems with ΔδT < 4.0 MPa^1/2. A combination of Hansen solubility parameters with experimental drug-lipid miscibility tests can be successfully applied to predict lipids with the best solubilizing potential for different API prior to manufacture of solid lipid nanoparticles and nanostructured lipid carriers.

Keywords: Clarithromycin; Didanosine; Efavirenz; Hansen solubility parameter; Lipid nanoparticles and nanocarriers; Minocycline hydrochloride; Mometasone furoate; Solubility.